Finnish researchers say they have discovered how a new cancer therapy can alter the function of immune cells to enable them to infiltrate tumours previo.
Researchers at the University of Turku, Finland, have uncovered how the new bexmarilimab therapy alters the function of immune cells so that they can infiltrate the tumor in cancer patients who do not respond to any other current therapies.
Cancer therapy bexmarilimab awakens immune cells to attack tumors that have avoided detection, research finds medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Researchers from the University of Turku s InFLAMES flagship program have made a breakthrough in cancer treatment with the development of Beksmarilimab, a new drug that reactivates white blood cells within tumors that have been hiding from the immune system. This promising discovery offers a new avenue for cancer immunotherapy, particularly for patients who have shown a favorable response to the drug.
Two new Finnish studies show that short bouts of light or moderate exercise can increase the number of immune cells in the bloodstream of cancer patie..